Cargando…
Blockchains, Formulary Evaluations and Health Technology Assessment
Blockchains have the potential, if appropriately implemented and managed, of contributing to a fundamental change in the application of techniques of health technology assessment in formulary decision making. Rather than continuing to rely on claims made by manufacturers that are non-evaluable, the...
Autores principales: | Langley, Paul C, Martin, Robert E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640768/ https://www.ncbi.nlm.nih.gov/pubmed/34007722 http://dx.doi.org/10.24926/iip.v9i4.1445 |
Ejemplares similares
-
If You Build it Will They Come? Patients, Providers and Blockchains in Health Technology Assessment
por: Langley, Paul C, et al.
Publicado: (2018) -
Blockchains, Property Rights and Health Technology Assessment in the Pharmaceutical and Device (s) Industries
por: Langley, Paul C, et al.
Publicado: (2018) -
Value Assessment, Real World Evidence and Fundamental Measurement: Version 3.0 of the Minnesota Formulary Submission Guidelines
por: Langley, Paul C
Publicado: (2020) -
Formulary Submissions: Value Claims, Protocols and Outcomes Based Contracting in Rare Disease
por: Langley, Paul C
Publicado: (2022) -
Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
por: Langley, Paul C
Publicado: (2021)